Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

Katheterablation bei Vorhofflimmern – gibt es einen Mortalitätsvorteil bei Patienten mit Diabetes und Herzinsuffizienz?

Journal

Herz
ISSN: 1615-6692
Titre abrégé: Herz
Pays: Germany
ID NLM: 7801231

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 9 3 2019
medline: 8 10 2019
entrez: 9 3 2019
Statut: ppublish

Résumé

Atrial fibrillation (AF) is the most commonly sustained arrhythmia, and patients with diabetes mellitus (DM) exhibit an increased incidence of AF. Besides DM, heart failure (HF) shares pathophysiological links with AF, mainly related to the pathological remodeling of hearts affected by structural disease. As in a vicious circle, AF may contribute to HF worsening and increased mortality in patients with structural heart diseases, and the outcome may be further impaired when concomitant DM is present. Although no data directly referring to DM patients with HF are available, indirect information can be drawn from large studies on patients with HF and AF. The present review discusses the outcome of AF ablation in patients with DM and HF, focusing on safety, efficacy, and most particularly on hard endpoints such as mortality and thromboembolic event incidence.

Identifiants

pubmed: 30847508
doi: 10.1007/s00059-019-4794-7
pii: 10.1007/s00059-019-4794-7
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-222

Références

J Am Coll Cardiol. 2004 Mar 17;43(6):1004-9
pubmed: 15028358
Europace. 2004 Sep;5 Suppl 1:S5-19
pubmed: 15450275
N Engl J Med. 2004 Dec 2;351(23):2373-83
pubmed: 15575053
Eur Heart J. 2005 Jul;26(13):1303-8
pubmed: 15767288
Int J Cardiol. 2005 Dec 7;105(3):319-21
pubmed: 16274776
Anesth Analg. 2006 Sep;103(3):545-50
pubmed: 16931659
J Am Coll Cardiol. 2008 Feb 26;51(8):802-9
pubmed: 18294563
Herz. 2008 Apr;33(3):170-7
pubmed: 18568310
Herz. 2008 Apr;33(3):184-90
pubmed: 18568312
Eur Heart J. 2009 May;30(9):1128-35
pubmed: 19282274
Eur J Heart Fail. 2009 Jul;11(7):676-83
pubmed: 19553398
Rev Endocr Metab Disord. 2010 Mar;11(1):87-94
pubmed: 20204530
Eur Heart J. 2010 Dec;31(24):3040-5
pubmed: 20935002
Am J Cardiol. 2011 Jul 1;108(1):56-62
pubmed: 21529739
Int J Cardiol. 2012 Jun 14;157(3):397-402
pubmed: 21652096
Heart. 2012 Jan;98(2):133-8
pubmed: 21930722
Eur Heart J. 2012 Apr;33(7):904-12
pubmed: 21990265
Herz. 2012 May;37(3):258-63
pubmed: 22453912
Circulation. 2012 Nov 6;126(19):2353-62
pubmed: 23129702
J Cardiovasc Electrophysiol. 2013 Jan;24(1):24-32
pubmed: 23140485
Am J Cardiol. 2013 Mar 1;111(5):748-53
pubmed: 23273718
Eur J Heart Fail. 2013 Apr;15(4):415-24
pubmed: 23302606
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):31-8
pubmed: 24382410
Int J Cardiol. 2014 Mar 1;172(1):40-6
pubmed: 24447747
Expert Rev Cardiovasc Ther. 2014 Mar;12(3):323-9
pubmed: 24460120
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1011-8
pubmed: 25262686
Herz. 2015 Apr;40 Suppl 2:130-6
pubmed: 25336239
J Cardiovasc Electrophysiol. 2015 Apr;26(4):363-370
pubmed: 25534572
Expert Rev Cardiovasc Ther. 2015 Jun;13(6):643-51
pubmed: 26000562
Europace. 2015 Oct;17(10):1518-25
pubmed: 26498716
Eur J Heart Fail. 2015 Oct;17(10):1003-5
pubmed: 26511145
Europace. 2016 Nov;18(11):1711-1718
pubmed: 26838688
Europace. 2016 May;18(5):638-47
pubmed: 26857188
Circulation. 2016 Apr 26;133(17):1637-44
pubmed: 27029350
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Int J Cardiol. 2017 Aug 1;240:240-245
pubmed: 28258848
Am J Cardiol. 2017 Nov 1;120(9):1572-1577
pubmed: 28886855
Europace. 2018 Sep 1;20(9):1428-1434
pubmed: 29165582
Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):172-179
pubmed: 29309557
Am J Cardiol. 2018 Mar 1;121(5):602-608
pubmed: 29331355
Diab Vasc Dis Res. 2018 May;15(3):185-195
pubmed: 29338326
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358
Herz. 2018 May 2;:null
pubmed: 29721589
JACC Clin Electrophysiol. 2018 May;4(5):626-635
pubmed: 29798790
J Am Heart Assoc. 2018 Jun 15;7(12):null
pubmed: 29907655
J Cardiovasc Electrophysiol. 2019 Apr;30(4):479-486
pubmed: 30575179
Heart. 1997 Apr;77(4):309-13
pubmed: 9155607
Int J Clin Pharmacol Res. 1998;18(3):109-20
pubmed: 9825267

Auteurs

M Matta (M)

Division of Cardiology, Sant'Andrea Hospital, Vercelli, Italy.

A Saglietto (A)

Division of Cardiology, Department of Medical Sciences, "Città della Salute e della Scienza" Hospital, University of Turin, Corso Bramante 88, 10126, Turin, Italy.

P De Salvo (P)

Division of Cardiology, Department of Medical Sciences, "Città della Salute e della Scienza" Hospital, University of Turin, Corso Bramante 88, 10126, Turin, Italy.

A Bissolino (A)

Division of Cardiology, Department of Medical Sciences, "Città della Salute e della Scienza" Hospital, University of Turin, Corso Bramante 88, 10126, Turin, Italy.

A Ballatore (A)

Division of Cardiology, Department of Medical Sciences, "Città della Salute e della Scienza" Hospital, University of Turin, Corso Bramante 88, 10126, Turin, Italy.

M Anselmino (M)

Division of Cardiology, Department of Medical Sciences, "Città della Salute e della Scienza" Hospital, University of Turin, Corso Bramante 88, 10126, Turin, Italy. matteo.anselmino@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH